Introduction
Iron is an essential nutrient required for a variety of biochemical processes such as respiration, metabolism, and DNA synthesis. To maintain intracellular iron levels, cells possess tightly regulated mechanisms for iron absorption and metabolism. Transferrin (Tf), the major iron transport protein in the blood, is taken up into cells by binding to the transferrin receptor 2 (Tf R2). This homodimeric membrane receptor binds 2 Tf molecules and is internalized into endosomes that are acidified, resulting in the release of iron from Tf. Iron is transported across the vesicle membrane for utilization and/or storage within the cell, and the Tf R-Tf complex recycles back to the cell surface where apo-Tf is released at the higher pH of blood (pH 7.4; reviewed in Aisen et al 1 ) . The Tf R plays a critical role in iron homeostasis. The Tf R knock-out mouse results in embryonic lethality. 2 The recently identified TfR2, a second distinct Tf receptor, is most likely responsible for the non-TfR-mediated uptake of Tf into cells, and it also plays a critical role in iron homeostasis. 3 Mutations in this gene are associated with a rare form of hemochromatosis unrelated to mutations in the hereditary hemochromatosis protein, HFE. 3 TfR2 can support growth of a transfected Chinese hamster ovary cell line lacking endogenous transferrin receptors when given Tf as an iron source. 4 However, TfR2 expression is not sufficient to replace the function of TfR, because mice in which the TfR gene has been deleted die as embryos. 2 TfR2, like TfR, is a type II membrane glycoprotein with a large C-terminal ectodomain and a small N-terminal cytoplasmic domain. 5, 6 TfR2 shares 45% amino acid sequence identity with TfR in the extracellular region, contains a cytoplasmic internalization motif similar to TfR, and has 2 cysteines, which form intersubunit disulfide bonds, in the ectodomain proximal to the transmembrane domain. 5, 6 Clear differences exist between the 2 transferrin receptors despite their similarities. Both receptors bind diferric Tf better than apotransferrin at neutral pH, however the affinity of Tf R2 for Tf is approximately 25-fold lower than that of Tf R. 5 While Tf R and HFE are associated in the placenta and transfected cells, 7, 8 and in vitro binding assays demonstrate that the ectodomain of Tf R binds to HFE with nM affinity, [9] [10] [11] the Tf R2 ectodomain does not detectably bind to HFE. 12 In humans and mice, Tf R2 is expressed predominantly in liver and erythroid cells, while Tf R is expressed in a wider range of tissues. 5, 6, 13 Even though the ectodomains of the 2 Tf Rs are similar, their cytoplasmic domains share no sequence homology. Tf R expression is controlled primarily at the posttranscriptional level in response to cellular iron levels, while Tf R2 expression is not influenced by changes in cellular iron levels. [4] [5] [6] Tf R2 expression is controlled at the transcriptional level by the erythroid transcription factor GATA-1. 14 Although Tf R2 can mediate cellular iron uptake in transfected cells, little is known about its physiologic function and potential interaction with Tf R in cell lines that express both receptors. In this study, we investigated the interaction of Tf R and Tf R2 from the K562 chronic myelogenous cell line with erythrocytic features and from human liver tissue, and we compared the quantities and cellular localization of each receptor. Tf R is more abundant than Tf R2 in K562 cells while the reverse is true in human liver. We found that in K562 cells Tf R and Tf R2 colocalize, but coprecipitate to only a limited extent. In liver, only limited coprecipitation of the 2 receptors is detected. These data suggest that homotypic more than heterotypic interactions at the dimer interface are favored.
Materials and methods

Generation of monoclonal antibodies to Tf R and Tf R2
Soluble versions of human Tf R and Tf R2 were expressed separately in a lytic baculovirus/insect cell expression system as described previously. 9, 12 Briefly, constructs encoding the ectodomain of Tf R or Tf R2 were joined to a gene segment encoding the leader peptide from the baculovirus protein GP67, a 6xHis-tag, and a Factor Xa cleavage site in a modified form of the pAcGP67A expression vector (Pharmingen, San Diego, CA). Recombinant virus was generated by cotransfection of the transfer vector with linearized viral DNA (Baculogold; Pharmingen). Tf R or Tf R2 was purified from supernatants of baculovirus-infected High 5 cells using nickel-nitrilotriacetic acid chromatography (Ni-NTA Superflow; Qiagen, Valencia, CA) followed by gel filtration chromatography using a Superdex 200 fast protein liquid chromatography column (Amersham Pharmacia Biotech, Piscataway, NJ). Monoclonal antibodies 3B8 2A1 and 9F8 1C11 were generated against the purified ectodomains of the human Tf R and human Tf R2, respectively. Female BALB/c mice (aged 5 weeks) were primed and boosted twice (at 2-week intervals) by intraperitoneal injection of 100 g of the purified ectodomain of Tf R2 or Tf R in adjuvant. Serum was screened one week after each injection by enzyme-linked immunoassay (ELISA) as described. 15 At 3 days preceding the fusion, one mouse was boosted with 100 g of purified Tf R2 or Tf R. Splenocytes from the boosted mouse were fused with HL-1 murine myeloma cells. Media from the hybridoma cultures were tested for antibodies against Tf R2 or Tf R by ELISA and subsequently by Western blotting. After subcloning positive clones at clonal density, ascites tumors were produced in pristine-primed BALB/c mice. These monoclonals were selected by ELISA assay and then screened for their ability to detect Tf R2 or Tf R by Western blot analysis. Both antibodies were the immunoglobulin G1 (IgG1), subtype. Antibodies to Tf R2 did not interact with the ectodomain of Tf R by either Western blot or ELISA analysis. The opposite was also true.
Cell lines
HepG2 cells (human hepatocarcinoma) were obtained from the Vollum Institute (Portland, OR), Huh7 cells (human hepatocarcinoma) were kindly provided by Dr Philip Aisen (Einstein University, Bronx, NY). TRVb1 and TRVb cells were gifts of Dr Tim McGraw (Cornell Medical College, New York, NY). The TRVb2 cell line was generated by transfection of TRVb cells with pCDNA 3.1 encoding Tf R2 with a FLAG epitope on the N-terminus, selected with G418, and subcloned as described previously. 16 The plasmid was the gift of Drs Koeffler and Kawabata (University of California, Los Angeles). All other cell lines were obtained from the American Type Culture Collection (ATCC; Manassas, VA).
Immunodetection
K562 cells were maintained in RPMI-1640 (Sigma, St Louis, MO) supplemented with 10% fetal bovine serum. Cells were collected and counted on a hemocytometer, washed 3 times with ice-cold phosphatebuffered saline (PBS; pH 7.4) and lysed at a concentration of 1 ϫ 10 7 cells/mL in NET-Triton buffer (150 mM NaCl, 5 mM EDTA [ethylenediaminetetraacetic acid], 10 mM Tris, pH 7.4, 1% Triton X-100). Cell extracts were incubated with 2 ϫ Laemmli buffer 17 and subjected to electrophoresis on 8% polyacrylamide gels under both reducing and nonreducing denaturing conditions. Separated proteins were transferred to nitrocellulose and blocked overnight at 4°C with 5% milk in 0.01 M Tris-HCl, 0.15 M NaCl, pH 7.4, plus 0.05% Tween-20. Immunoblot analysis was performed using either a sheep anti-Tf R serum (1:10 000 dilution) 18 or the monoclonal anti-Tf R2 (9F8 1C11) antibody (1:10 000 dilution) followed by the appropriate secondary antibody conjugated to horseradish peroxidase and chemiluminescence (Supersignal; Pierce, Rockford, IL) per the manufacturer's directions.
Immunoprecipitation
K562 cells were washed 3 times with ice-cold PBS and lysed with NET-Triton buffer (0.05 M Tris-Cl, 0.15 M NaCl, 5 mM EDTA, pH 7.4, 1% Triton X-100) followed by centrifugation at 2000g for 5 minutes to remove nuclei. Cell lysates were incubated for 60 minutes at 4°C with either 25 L of protein A-Sepharose (Amersham Pharmacia Biotech) or 25 L of protein A-Sepharose coated with affinity-purified rabbit anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), and 1.5 L of either sheep anti-Tf R serum or mouse anti-Tf R2. The pellet was resuspended into 100 L NET-Triton buffer, layered on top of 1 mL of the same buffer with 15% sucrose, and pelleted. Samples were eluted in 30 L of 2 ϫ Laemmli buffer, 17 subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis on an 8% polyacrylamide gel, transferred to nitrocellulose, and immunodetected for either Tf R or Tf R2.
Quantitation of Tf R and Tf R2
Subconfluent K562 cells were incubated overnight at 37°C in RPMI-1640 medium without methionine (Life Technologies, Invitrogen, Carlsbad, CA) with 50 Ci (1.85 MBq) of 35 S-methionine/cysteine with 10% fetal bovine serum. The cells were then washed 3 times with ice-cold PBS and lysed in NET-Triton, and the nuclei pelleted. Cell extracts were subjected to immunoprecipitation with either sheep anti-Tf R or mouse anti-Tf R2 antibody as described in "Immunoprecipitation" and analyzed by SDS-PAGE on an 8% acrylamide gel under reducing and denaturing conditions. Gels were fixed, treated with Amplify (Amersham Pharmacia Biotech) for 30 minutes, dried, and exposed to a PhosphorImager screen (Amersham Pharmacia Biotech). Quantitation of the amount of Tf R and Tf R2 took into account the differences in methionine and cysteine composition of the 2 receptors (22 Met and Cys for Tf R and 15, for Tf R2).
Interaction of soluble HFE with cell extracts
Cell extracts from K562 cells were incubated with the ectodomain of purified recombinant HFE/␤ 2 microglobulin (final concentration 1 M) for 60 minutes at 4°C (K562 ϩ HFE) and immunoprecipitated using sheep anti-Tf R serum and Staphylococcus aureus (Pansorbin; Calbiochem, San Diego, CA). The ectodomain of purified recombinant HFE/␤ 2 microglobulin was generated as previously described. 9 Immunoprecipitated proteins were subjected to SDS-PAGE on an 8% acrylamide gel, transferred to nitrocellulose, and immunodetected for Tf R2 or Tf R.
Immunohistochemistry
K562 cells were fixed in 4% paraformaldehyde, blocked with 2.5 mg/mL bovine serum albumin (BSA), then incubated with sheep anti-Tf R (1:50) and mouse anti-Tf R2 antibody (1:300) for 1 hour at room temperature. Cells were layered onto 500 L of fetal bovine serum, centrifuged at 1000g for 2 minutes, and resuspended, followed by incubation for 60 minutes with both Alexa 488 conjugated donkey antisheep antibody (1:500) (Molecular Probes, Eugene, OR) and donkey anti-mouse IgG (Jackson ImmnunoResearch Laboratories) conjugated to Alexa 594 using an Alexa Fluor 594 Protein Labeling Kit (1:100) (Molecular Probes). Cells were again layered on top of 500 L fetal bovine serum, pelleted, washed with PBS, and mounted on slides using Prolong Antifade (Molecular Probes). Images were obtained using a BioRad 1024 ES laser scanning confocal system (Hercules, CA) on a Nikon Eclipse TE300 microscope (Melville, NY) with a ϫ 60 oil immersion Planapo objective. Permeabilized cells were treated with NET-Triton after fixation and prior to incubation with antibodies.
Results
Characterization of Tf R2 expression
The relative amounts of Tf R2 in a variety of human cell lines were visualized by Western blot analysis using the mouse monoclonal antibody (9F8 1C11) against the ectodomain of human Tf R2 ( Figure 1A ). Closely migrating bands (2-3) of between approximately 97 and 105 kDa were observed for Tf R2. Multiple bands have been observed previously and have been attributed to heterogeneity in glycosylation. 4 The Tf R2 signal was strongest in K562 and HEL 92 cells (erythroleukemia cell lines), moderate in HepG2 and Huh7 cells (hepatoblastoma cell lines), and undetectable in the Hep3B and SK1 Hep cell lines (hepatoblastoma cell lines). These results correlate with previous work, which demonstrated that Tf R2 mRNA was expressed strongly in both K562 and HepG2 cells by Northern blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. 5 In contrast, Tf R protein levels were strong and uniform in these and other cell lines tested (data not shown).
Quantitation of Tf R and Tf R2 in K562 cells
To measure the relative amounts of Tf R and Tf R2 protein, cell lysates from 35 S-methionine/cysteine-labeled K562 cells were immunoprecipitated with either a sheep antihuman Tf R antiserum or the mouse antihuman Tf R2 monoclonal antibody (9F8 1C11), separated on a 8% acrylamide gel under reducing and denaturing conditions, dried, and exposed to a PhosphorImager ( Figure 1B) . The amount of Tf R2 protein is approximately 20 times less than Tf R protein. Background of the 35 S-labeled immunoprecipitates prevented the quantitation of the amount of each receptor that formed heterodimers. We estimate that if 5% of Tf R formed heterodimers with Tf R2 then Tf R should have been detectable in the Tf R2 immunoprecipitates. If less than 25% of the Tf R2 coprecipitated with Tf R1 then the heterodimers would not be detectable by this method. Thus although the 2 Tf R receptors coprecipitate in K562 cells, the coprecipitated material accounts for only less than 5% of the total amount of receptors.
Tf R and Tf R2 association
A series of immunoprecipitations and Western blots of the immunoprecipitated proteins were performed using Tf R and Tf R2 antibodies to determine the relative amounts of each protein in this cell line (Figure 2 ). When Tf R was immunoprecipitated from K562 cell lysates followed by Western blotting for Tf R2, Tf R2 clearly coimmunoprecipitates with Tf R (Figure 2A immunoreactive bands (Figure 2A , lane 2 and 2B, lane 2, respectively). To measure the total amount of Tf R2 and Tf R that immunoprecipitated, a series of control blots were performed ( Figure 2C-D) . Immunoprecipitation with Tf R2 antibody and S aureus, followed by immunodetection for Tf R2, shows that Tf R2 can be quantitatively precipitated with this antibody ( Figure 2C,  lanes 1,4) . Similarly, Tf R can be quantitatively precipitated from lysates ( Figure 2D, lanes 1,4) . These results indicate that that homodimer formation is strongly preferred.
We also tested to determine if the 2 receptors had to be expressed in the same cell in order to associate or if higher order complexes formed only after the cells were lysed. For these experiments, we transfected TRVb cells, a Chinese hamster ovary cell line lacking endogenous transferrin receptor. 19 A series of immunoprecipitations were carried out with TRVb cells stably transfected with Tf R (TRVb1) or Tf R2 (TRVb2) (Figure 3 ). When cell lysates from these 2 cell lines were mixed and immunoprecipitated with anti-Tf R2, no Tf R could be detected ( Figure 3A) . Similarly, immunoprecipitation of a mixture of cell lysates from the 2 cell lines with anti-Tf R shows no detectable Tf R2 in the immunoprecipitates ( Figure 3B ). These results indicate that the 2 homodimers generated in separate cell lines do not form higher order complexes after solubilization.
Colocalization of Tf R and Tf R2 in K562 cells
Confocal microscopy was used to examine the intracellular locations of TfR and TfR2. K562 cells were fixed and incubated with either a sheep anti-TfR serum or the mouse anti-TfR2 antibody, followed by appropriate fluorescent secondary antibodies (Figure 4) . Prior experiments (Figures 1-2 ) demonstrated that TfR and TfR2 are both expressed in erythroid and liver cell lines and that they can associate to form heterodimers; yet the extent to which these proteins share similar subcellular locations was unknown. Confocal images of stained cells demonstrate that TfR and TfR2 localize in overlapping subcellular compartments. In both nonpermeabilized cells ( Figure 4A 
HFE and Tf do not prevent association between Tf R and Tf R2
Crystallographic studies of the HFE-TfR complex reveal that the HFE binding site on TfR comprises 2 helices on the outer edge of the helical domain. 22 In vitro studies using the ectodomains of TfR, HFE, and Tf suggest that HFE and Tf compete with each other for binding to TfR 23 and are consistent with the demonstration that site-directed mutagenesis of the HFE binding site on TfR affects Tf binding. 11 We wanted to test whether the TfR2 interaction site on TfR overlapped with the region on the TfR helical domain identified as the HFE and Tf binding site. Extracts of K562 cells were incubated in the presence of 100 M soluble recombinant HFE, 10 
Tf R and Tf R2 interaction under nonreducing conditions
Because Tf R and Tf R2 each contain cysteine residues that are used for intersubunit disulfide bonds, a possible mode of association between Tf R and Tf R2 is the formation of covalent, disulfidelinked heterodimers ( Figure 6 ). To determine whether covalent Tf R-Tf R2 heterodimers can form, cell lysates from K562 and TRVb1 cells were examined under nonreducing conditions and Tf R and Tf R2 were immunodetected on Western blots. A single homodimer band will be seen at approximately 186 kDa and a monomeric band will be detected at approximately 93 kDa for Tf R if the receptors interact yet do not form intersubunit disulfide bonds. The migration pattern of Tf R2 under nonreducing conditions is more complicated because it migrates as a doublet under reducing conditions. If Tf R and Tf R2 form intersubunit disulfide bonds, then Tf R should be detected as a doublet with the lower molecular mass at approximately 186 kDa and little or no 
Interaction of Tf R and Tf R2 in human liver tissue
Because Tf R and Tf R2 interact with each other in K562 cells we wanted to determine whether this interaction could be detected in the liver, the tissue that has the highest concentration of Tf R2 mRNA. Western blots were used to evaluate the relative levels of Tf R2 in K562 cells and liver tissue. Tf R2 is much more abundant in liver compared with K562 cells. The opposite is true for Tf R. Tf R is barely detectable in liver and easily detected in K562 cells ( Figure 7A ). Similar to K562 cells, small but detectable amounts of Tf R2 and Tf R coprecipitate, indicating that the 2 receptors interact in liver as well as K562 cells but, again, to only a limited extent. Sections in panels D to G are 1.5 m apart; panels J and K are separate Tf R (green) and Tf R2 (red) channels of image in panel E. Images were captured with a ϫ 60 oil immersion lens as described in "Materials and methods." Figure 5 . HFE does not alter Tf R-Tf R2 interaction. Cell extracts from K562 cells were incubated with 1 M purified recombinant HFE for 60 minutes at 4°C (K562 ϩ HFE) and immunoprecipitated using sheep anti-Tf R serum and S aureus (IP:Tf R). Immunoprecipitated proteins were subjected to SDS-PAGE on an 8% gel, transferred to nitrocellulose, and immunodetected for Tf R2 (upper panel) (WB:Tf R2) and Tf R (lower panel) (WB:Tf R). NS indicates background control using K562 cell extracts and S aureus without antibody; vertical dash, no cell extract with anti-Tf R and S aureus only; and CE, cell extract. 
Discussion
Tf is the major iron transport protein in the blood and was originally thought to bind to and be taken up into cells via only a single receptor, Tf R. Recently however, 2 more Tf binding receptors have been identified, Tf R2 5, 6 and the cubulin-megalin complex. 24 These 2 receptors for Tf are tissue specific, whereas Tf R appears to be expressed at least at low levels ubiquitously. Tf R2 is expressed mainly in the liver and erythropoietic cells, and the cubulin-megalin complex is localized in the kidneys and rat yolk sac. 24 Each receptor presumably has a different function in the regulation of iron homeostasis in the body. Tf R regulates the uptake of iron into cells and itself is regulated by intracellular iron concentrations and by the proliferation status of the cells. The cubulin-megalin complex appears to be essential in the scavenging of iron, which would otherwise be excreted by the kidneys. The function of Tf R2 has not been elucidated to date. It likely plays a major role in iron homeostasis in the body because mutations in this gene result in a rare form of hereditary hemochromatosis with iron accumulation in the liver, heart, and pancreas and high levels of Tf iron saturation. 3 The interactions between these 3 transferrin receptors have not been examined. There is probably no interaction between the cubulin-megalin complex and Tf R. They are located in different regions of the cell: the cubulin-megalin complex apically oriented, and the Tf R basolaterally oriented. Here we used a cell line that endogenously expresses both Tf R and Tf R2 in order to study their interaction. We found the highest levels of Tf R2 protein present in K562 and HEL92 erythroleukemia cell lines, with lesser amounts in HepG2 and Huh7 liver cell lines, correlating with previous work Residues in the Tf R dimer interface were identified by contact analysis in CNS 25 of the unliganded Tf R structure (1CX8.pdb) 26 using a probe radius of 1.4 Å and a distance cutoff of 4 Å. The interface is 70% identical between Tf R and Tf R2, consistent with the observation of Tf R-Tf R2 heterodimers. Nonconservative substitutions are underlined and semiconservative substitutions are italicized. Nonconservative substitutions with an asterisk could probably be accommodated in the dimer interface, as determined by inspection of the Tf R structure. For example, the substitutions at Tf R position 668 and 669 would disrupt a cation-interaction between an arginine and a phenylalanine and replace it with a salt bridge between a glutamate and an arginine.
by Kawabata et al, which demonstrated high levels of Tf R2 mRNA expression in erythroid precursors and liver. 5, 14 In K562 cells, Tf R2 levels are approximately 10 times lower than Tf R levels; however, the 2 receptors have similar cellular distributions, with most of both receptors in the cell interior. Being 10 times more abundant and possessing a higher affinity for Tf, Tf R is responsible for the majority of iron uptake in this cell line. However, Tf R2 mRNA and protein levels are more abundant than Tf R mRNA and protein levels in liver and immature erythroid precursors, suggesting that Tf R2 protein predominates in these cells. 4, 6 We have demonstrated an interaction between Tf R and Tf R2. Studies using coprecipitation and nonreducing SDS-PAGE show that the transferrin receptors interact and form heterodimers, and this in vitro interaction is supported by the similar colocalization of Tf R and Tf R2 in vivo. On the cell surface both receptors appear diffuse and in similar locations, while on the cell interior both receptors colocalize to punctate vesicles, likely the recycling endosome. These results suggest that similar mechanisms are used in the internalization and trafficking of each receptor within the cell, even though the amino acid sequences of the cytoplasmic domains of each receptor share no similarity other than both containing tyrosine-based internalization motifs.
HFE and Tf do not prevent Tf R-Tf R2 association, suggesting Tf R2 binds to Tf R somewhere other than the common HFE and Tf binding site on Tf R. Another possibility is that Tf R and Tf R2 formed mixed heterodimers. This suggestion is supported by the observation of the mixed covalent heterodimers and by the fact that many of the residues at the crystallographically determined Tf R dimerization interface are conserved in Tf R2 (Table 1) .
How the interaction between these 2 transferrin receptors affects their function remains to be studied. The subunits of Tf R and Tf R2 do not interact equally well with each other. Tf R and Tf R2 preferentially form homodimers, and only a small percentage form heterodimers. From crystallographic studies, HFE interacts with Tf R via a hydrophobic region on the ectodomain of the receptor, competing with Tf for binding to Tf R. 9, 23 Because Tf R2 is not regulated in response to changes in cellular iron levels and does not interact with HFE, the Tf R-Tf R2 interaction could function as a potential mechanism to regulate iron uptake in unique ways, perhaps by utilizing signaling pathways. If this were the case, then the heterodimers could be potentially important in regulating signaling. Additional studies are required to fully understand the role of Tf R2 and the relationship of Tf R2 with Tf R.
